Thanks irenekwshiu, I'm excited about the adult trial - just need the "second potency assay signed off".
What was frustrating is that shareholders were not informed we were part of an EAP in the first place. We get told we are double the survival percentage of the only approved product as an aside. Marketing is not our CEO's strong suit
Reg
Ann: Half Year Financial Results Presentation, page-66
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.030(3.19%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 98.0¢ | 92.0¢ | $2.380M | 2.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 55173 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 82276 | 16 |
View Market Depth
| Last trade - 13.28pm 03/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |